51182426 Cinacalcet

Definition

UNSPSC 51182426

This classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula C22H22F3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UAZ6V7728S, chemically known as 1-naphthalenemethanamine, a-methyl-n-(3-(3-(trifluoromethyl)phenyl)propyl)-, (ar)- but generally known as cinacalcet, which bears US NIH Compound Identifier 156419. European Medicines Agency schedules Cinacalcet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20068. The term CINACALCET is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 4, 2003, List 50). World Health Organization schedules cinacalcet in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cinacalcet under HS 29214980 and SITC 51454. As of Q4 2014, CINACALCET remains the US FDA Preferred Term for this commodity. Cinacalcet bears US NLM identifiers UMLS ID C1337242 and NCI Concept Code C74100. SMILES: FC(F)(F)C1CC(CCCNC(C2C3C(CCC2)CCCC3)C)CCC1.

Same parent

Under 51182400 · 28

51182401 Calcium chloride Commodity 51182405 Dibase calcium phosphate Commodity 51182406 Alendronic acid or alendronate sodium Commodity 51182408 Cellulose sodium phosphate Commodity 51182410 Etidronate Commodity 51182412 Tribasic calcium phosphates Commodity 51182413 Calcium glycerophosphate or calcium glycero phosphate Commodity 51182415 Zoledronic acid Commodity 51182416 Pamidronate disodium or pamidronic acid Commodity 51182417 Risedronate sodium or risedronic acid Commodity 51182418 Calcium acetate Commodity 51182423 Ibandronate or ibandronic acid Commodity 51182425 Butedronic acid Commodity 51182426 Cinacalcet You are here 51182427 Clodronate or clodronic acid Commodity 51182428 Denosumab Commodity 51182429 Strontium ranelate Commodity 51182430 Etidronic acid Commodity 51182431 Ipriflavone Commodity 51182432 Minodronic acid Commodity 51182433 Neridronic acid Commodity 51182434 Olpadronic acid Commodity 51182435 Teriparatide Commodity 51182436 Tiludronic acid Commodity 51182437 Cinacalcet hydrochloride Commodity 51182438 Teriparatide acetate Commodity 51182439 Teriparatide recombinant human Commodity 51182440 Cholecalciferol/Risedronate sodium or risedronic acid Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51180000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class